PLRX SCHEDULE 13G: SEC filing
Adar1 Capital Management, LLC and Daniel Schneeberger
Filed with the SEC on · accession 0001104659-26-097422
PLRX filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -0.9% by the first close after the filing.
Summary of the filing
Adar1 Capital Management, LLC and Daniel Schneeberger filed a Schedule 13G joint filing agreement regarding their beneficial ownership of Pliant Therapeutics, Inc. common stock.
Key details
How PLRX stock reacted
Close before
$1.08
Aug 13, 2026
First close after
-0.93%
$1.07
5 trading days
+3.70%
$1.12
Since filing
-24.46%
$0.82
✦ Ask GOAX AI about this filing — what it means for PLRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PLRX?
Click hereFrequently asked questions
What did PLRX file with the SEC on Aug 14, 2026?
PLRX filed a SCHEDULE 13G (SEC filing). Adar1 Capital Management, LLC and Daniel Schneeberger filed a Schedule 13G joint filing agreement regarding their beneficial ownership of Pliant Therapeutics, Inc. common stock.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did PLRX stock react to this filing?
PLRX closed at $1.08 before the filing and $1.07 on Aug 14, 2026 (-0.93%). Five trading days later: $1.12 (+3.70%).
Other PLRX SEC filings
Get alerts when PLRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days